Maryland Proton Treatment Holdings, LLC, the operator of the Maryland Proton Treatment Center (MPTC) has named Michael E. Cryor and Leigh T. Howe, two highly regarded members of Maryland’s business and healthcare communities, to its board of directors.

Mr. Cryor is President of The Cryor Group, LLC and a recognized strategic counselor and public leader. Ms. Howe is the current president and CEO of MPTC. Both are Baltimore natives.

Mr. Cryor is respected for his ability to facilitate large complex agreements with clients like Exelon Corporation, Northrop Grumman, Kaiser Permanente, the University of Maryland School of Medicine, and the Baltimore City School System. Mr. Cryor has also worked as psychologist and director of the Department of Consultation and Education at the Albert Einstein College of Medicine in New York; an associate dean at Morgan State University and in various executive positions in both chambers of the United State Congress, as well as the Maryland Democratic Party.

Ms. Howe, a healthcare finance executive and banker, became the MPTC President and CEO in June 2018. Ms. Howe has 40-years of experience working at major U.S. banks and private investment companies focusing on healthcare lending and investing.

“Mr. Cryor and Ms. Howe each have exceptional breadth and depth of experience as well as extensive relationships in the community. They are a tremendous asset to MPTC as we work to make proton therapy more accessible to providers and their patients,” says Dr. William F. Regine, MPTC’s Executive Director and professor and Isadore & Fannie Schneider Foxman Endowed Chair in Radiation Oncology at the University of Maryland School of Medicine.

“As Chair Emeritus of the University of Maryland School of Medicine Board of Visitors, I know first-hand that the Maryland Proton Treatment Center is among the finest in the country. The state of Maryland is very fortunate to have them. I look forward to serving as a member of its board of directors,” adds Mr. Cryor.

About the Maryland Proton Treatment Center

The Maryland Proton Treatment Center is the first health care organization to offer proton therapy in the Baltimore/Washington area. On February 23, 2016 MPTC opened its doors to provide a highly advanced and precise form of radiation therapy for adult and pediatric cancer patients that can increase the radiation dose to a tumor while decreasing the dose to healthy, surrounding tissues. MPTC is affiliated with the University of Maryland Marlene and Stewart Greenbaum Comprehensive Cancer Center (UMGCCC), an NCI-designated comprehensive cancer center and is located in the University of Maryland BioPark. The center has treated more than 2500 patients from the surrounding states and the globe. For more information on MPTC, proton therapy and treatable cancer/disease sites visit mdproton.com.